| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $0.52 (Miss by $-0.036) |
| EPS GAAP Actual | $0.52 (Miss by $-0.036) |
| Revenue Actual | $9.569B |
| Revenue Surprise | Beat by $9569M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Oct 2029 | 6.48 | 12.75 | 6.16002 | 6.68228 | 1 |
| Sep 2029 | 4.26 | 19.39 | 4.11262 | 4.51016 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.12 | 0.12 | 9.569B | 5.17% | 9569M |
| FQ2 2025 (Jun 2025) | 0.49 | 0.49 | 9.456B | 3.62% | 9456M |
| FQ1 2025 (Mar 2025) | 0.34 | 0.34 | 8.7616B | 2.27% | 8761.6M |
| FQ4 2024 (Dec 2024) | 0.69 | 0.69 | 9.3978B | -0.29% | 9397.8M |
| FQ3 2024 (Sep 2024) | 0.8 | 0.8 | 9.074B | -1.04% | 9074M |
| FQ2 2024 (Jun 2024) | 0.93 | 0.93 | 9.1139B | 4.32% | 9113.9M |
| FQ1 2024 (Mar 2024) | 0.68 | 0.68 | 8.563B | -1.76% | 8563M |
| FQ4 2023 (Dec 2023) | 0.9 | 0.9 | 9.4253B | 100% | 9425.3M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Sep 2028) | 0.96637 | -- | 0.93146 | 1.00195 | 6 |
| FQ2 2028 (Jun 2028) | 0.95736 | -- | 0.92278 | 0.99261 | 6 |
| FQ1 2028 (Mar 2028) | 0.6758 | -- | 0.65139 | 0.70068 | 6 |
| FQ4 2027 (Dec 2027) | 0.91845 | -- | 0.88527 | 0.95227 | 5 |
| FQ3 2027 (Sep 2027) | 1.18555 | -- | 1.16106 | 1.21582 | 9 |
| FQ2 2027 (Jun 2027) | 1.20151 | -- | 1.17669 | 1.23219 | 9 |
| FQ1 2027 (Mar 2027) | 0.83895 | -- | 0.82162 | 0.86037 | 9 |
| FQ4 2026 (Dec 2026) | 0.7992 | -- | 0.77033 | 0.82862 | 7 |
| FQ3 2026 (Jul 2026) | 1.21487 | 90.12 | 1.16113 | 1.30271 | 12 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Sep 2028) | 11.57B | -- | 11.25B | 11.9B | 7 |
| FQ2 2028 (Jun 2028) | 11.34B | -- | 11.03B | 11.66B | 4 |
| FQ1 2028 (Mar 2028) | 10.55B | -- | 10.26B | 10.85B | 4 |
| FQ4 2027 (Dec 2027) | 11.22B | -- | 10.9B | 11.53B | 10 |
| FQ3 2027 (Sep 2027) | 11.07B | -- | 10.9B | 11.29B | 9 |
| FQ2 2027 (Jun 2027) | 11.04B | -- | 10.87B | 11.26B | 15 |
| FQ1 2027 (Mar 2027) | 10.24B | -- | 10.08B | 10.44B | 8 |
| FQ4 2026 (Dec 2026) | 10.37B | -- | 10.08B | 10.67B | 9 |
| FQ3 2026 (Jul 2026) | 10.85B | 11.85 | 10.49B | 11.46B | 8 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.12 | 0.12 | 100% | |
| FQ2 2025 (Jun 2025) | 0.49 | 0.49 | 100% | |
| FQ1 2025 (Mar 2025) | 0.34 | 0.34 | 100% | |
| FQ4 2024 (Dec 2024) | 0.69 | 0.69 | 100% | |
| FQ3 2024 (Sep 2024) | 0.8 | 0.8 | 100% | |
| FQ2 2024 (Jun 2024) | 0.93 | 0.93 | 100% | |
| FQ1 2024 (Mar 2024) | 0.68 | 0.68 | 100% | |
| FQ4 2023 (Dec 2023) | 0.9 | 0.9 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $9.57B | $9569M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $9.46B | $9456M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $8.76B | $8761.6M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $9.4B | $9397.8M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $9.07B | $9074M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $9.11B | $9113.9M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $8.56B | $8563M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $9.43B | $9425.3M | 100% |